Legal & General Group PLC Heron Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 10,432 shares of HRTX stock, worth $16,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,432
Previous 10,432 -0.0%
Holding current value
$16,482
Previous $20,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$2.32 - $3.86 $489 - $814
-211 Reduced 1.98%
10,432 $36,000
Q4 2023

Feb 15, 2024
SELL
$0.54 - $1.82 $642 - $2,165
-1,190 Reduced 10.06%
10,643 $18,000
Q2 2023

Aug 14, 2023
SELL
$1.11 - $2.88 $9,328 - $24,203
-8,404 Reduced 41.53%
11,833 $13,000
Q1 2023

May 15, 2023
SELL
$1.51 - $3.25 $36,403 - $78,351
-24,108 Reduced 54.36%
20,237 $30,000
Q4 2022

Feb 14, 2023
SELL
$2.25 - $4.67 $2,684 - $5,571
-1,193 Reduced 2.62%
44,345 $110,000
Q3 2022

Nov 14, 2022
SELL
$2.66 - $5.37 $76,631 - $154,704
-28,809 Reduced 38.75%
45,538 $192,000
Q2 2022

Aug 22, 2022
BUY
$2.3 - $6.29 $2,562 - $7,007
1,114 Added 1.52%
74,347 $208,000
Q1 2022

May 16, 2022
BUY
$4.63 - $9.94 $5,495 - $11,798
1,187 Added 1.65%
73,233 $418,000
Q4 2021

Feb 14, 2022
BUY
$8.35 - $12.6 $1,845 - $2,784
221 Added 0.31%
72,046 $658,000
Q3 2021

Nov 15, 2021
BUY
$10.13 - $15.0 $187,678 - $277,905
18,527 Added 34.76%
71,825 $768,000
Q1 2021

May 17, 2021
BUY
$14.49 - $20.72 $7,708 - $11,023
532 Added 1.01%
53,298 $864,000
Q4 2020

Feb 12, 2021
SELL
$14.61 - $22.14 $1,694 - $2,568
-116 Reduced 0.22%
52,766 $1.12 Million
Q3 2020

Nov 13, 2020
SELL
$13.67 - $17.77 $52,328 - $68,023
-3,828 Reduced 6.75%
52,882 $783,000
Q2 2020

Aug 14, 2020
BUY
$10.89 - $21.47 $148,398 - $292,571
13,627 Added 31.63%
56,710 $835,000
Q1 2020

May 14, 2020
SELL
$10.23 - $24.56 $37,871 - $90,921
-3,702 Reduced 7.91%
43,083 $505,000
Q4 2019

Feb 13, 2020
BUY
$17.42 - $26.61 $105,303 - $160,857
6,045 Added 14.84%
46,785 $1.1 Million
Q3 2019

Nov 13, 2019
BUY
$16.36 - $21.39 $189,056 - $247,182
11,556 Added 39.6%
40,740 $754,000
Q2 2019

Aug 14, 2019
BUY
$16.93 - $26.22 $22,550 - $34,925
1,332 Added 4.78%
29,184 $543,000
Q1 2019

May 15, 2019
BUY
$23.15 - $28.34 $6,667 - $8,161
288 Added 1.04%
27,852 $680,000
Q4 2018

Feb 15, 2019
BUY
$22.03 - $32.01 $36,988 - $53,744
1,679 Added 6.49%
27,564 $716,000
Q3 2018

Nov 20, 2018
BUY
$30.0 - $40.85 $467,970 - $637,219
15,599 Added 151.65%
25,885 $819,000
Q2 2018

Aug 10, 2018
BUY
$26.4 - $42.0 $6,045 - $9,618
229 Added 2.28%
10,286 $400,000
Q1 2018

May 17, 2018
SELL
$18.43 - $28.8 $24,235 - $37,872
-1,315 Reduced 11.56%
10,057 $277,000
Q4 2017

Feb 13, 2018
BUY
$14.8 - $18.85 $168,305 - $214,362
11,372
11,372 $208,000

Others Institutions Holding HRTX

# of Institutions
179
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $188M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email